Corpus ID: 16370476

Review: the role of inflammation in depression.

@article{Patel2013ReviewTR,
  title={Review: the role of inflammation in depression.},
  author={Amisha Patel},
  journal={Psychiatria Danubina},
  year={2013},
  volume={25 Suppl 2},
  pages={
          S216-23
        }
}
  • Amisha Patel
  • Published 2013
  • Psychology, Medicine
  • Psychiatria Danubina
The role of inflammation in major depressive disorder (MDD) has been of growing interest over the past two decades and evidence suggests it plays a role in depression. Evidence linking inflammation to MDD comes from three different observations (a) elevated levels of inflammatory markers in patients with MDD, even in the absence of illness, (b) co-occurrence of MDD with inflammatory illnesses and (c) increased risk of MDD with cytokine treatment. Cytokines have been found to influence almost… Expand
Neuroimmunomodulation in Depression: A Review of Inflammatory Cytokines Involved in this Process
TLDR
The role of inflammation in depression, the possible mechanisms involved, and the possible treatments that act on the immune system are highlighted. Expand
Role of inflammatory cytokines in depression: Focus on interleukin-1β.
TLDR
The aim of the present review is to document recent literature regarding the impact of inflammatory mechanisms on the pathophysiology of the depressive disorder. Expand
Peripheral Markers of Depression
TLDR
Alterations in growth factors, with a significant decrease in brain-derived neurotrophic factor and an increase in fibroblast growth factors and insulin-like growth factor-1 concentrations have also been found in MDD. Expand
The common pathophysiology underlying the metabolic syndrome, schizophrenia and depression. A review.
TLDR
Further validation of existing schizophrenia and depression animal models are suggested for the assessment of metabolic disturbances to provide tools for developing new antipsychotics and antidepressants with "metabolically inert" profile or improving the metabolic status in schizophrenic/depressed patients. Expand
The cellular and molecular basis of major depressive disorder: towards a unified model for understanding clinical depression
TLDR
Key pathways discussed include neurotransmission, neuroinflammation, clock gene machinery pathways, oxidative stress, role of neurotrophins, stress response pathways, the endocannabinoid and endovanilloid systems, and the endogenous opioid system. Expand
Novel investigational drugs targeting IL-6 signaling for the treatment of depression
TLDR
The article outlines the therapeutic benefits of incorporating anti-inflammatory properties into the pharmacological treatment of MDD, and proposes inhibition of IL-6 signaling as a viable treatment strategy. Expand
Systems Genomics Support for Immune and Inflammation Hypothesis of Depression
TLDR
Integrative genomics evidence supports the immune and inflammation hypothesis of depression, with some of the genes identified in genome sequencing and proteomic analyses in human depression relating to immune and inflammatory pathways. Expand
Microglia: An Interface between the Loss of Neuroplasticity and Depression
TLDR
It is clear that all molecular pathways to depression are linked through microglia-associated neuroinflammation and hippocampal degeneration, and the various molecular pathways associated with the microglial role in depression are critically analyzed. Expand
Depression and Obesity: Integrating the Role of Stress, Neuroendocrine Dysfunction and Inflammatory Pathways
TLDR
The aim of this mini-review is to offer a reflexion on the interplay between the neuroendocrine dysfunctions related to chronic stress and the nature of the shared biologic mechanisms in the pathophysiology of both clinical entities, depression and obesity. Expand
PAI-1 as a component of the metabolic syndrome in depression and schizophrenia - Croatian experience.
TLDR
The role of the PAI-1 as the component of the MS in depression and schizophrenia is investigated, and the findings were consistent with those in the foreign literature. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 58 REFERENCES
Depression: an inflammatory illness?
TLDR
Inflammation may not only act as a precipitating factor that pushes a person into depression but also a perpetuating factor that may pose an obstacle to recovery, leading to the possibility of tailored treatments, thereby allowing stratification of what remains a heterogenous disorder. Expand
Inflammatory markers in depression
  • T. Dinan
  • Medicine
  • Current opinion in psychiatry
  • 2009
TLDR
Depression is an inflammatory state that may increase the risk of cardiac disease and whether or not the immune system is an appropriate target for antidepressant development has yet to be established. Expand
Is Depression an Inflammatory Disorder?
TLDR
Evidence is examined in support of the idea that inflammation only contributes to depression in a subset of patients versus the possibility that the depressogenic effect of inflammatory activation is more widespread and varies depending on the degree of vulnerability any given individual evinces in interconnected physiologic systems known to be implicated in the etiology of MDD. Expand
Cytokines sing the blues: inflammation and the pathogenesis of depression.
TLDR
These findings suggest that targeting proinflammatory cytokines and their signaling pathways might represent a novel strategy to treat depression. Expand
Inflammation in depression: is adiposity a cause?
Mounting evidence indicates that inflammation may play a significant role in the development of depression. Patients with depression exhibit increased inflammatory markers, and administration ofExpand
The Effect of Antidepressant Medication Treatment on Serum Levels of Inflammatory Cytokines: A Meta-Analysis
TLDR
Overall, while pharmacological antidepressant treatment reduced depressive symptoms, it did not reduce serum levels of TNFα, but antidepressant treatment did reduce levels of IL-1β and possibly those ofIL-6, which are consistent with the possibility that inflammatory cytokines contribute to depressive symptoms and that antidepressants block the effects ofinflammatory cytokines on the brain. Expand
Polymorphisms in inflammation-related genes are associated with susceptibility to major depression and antidepressant response
TLDR
The association of MDD and antidepressant response to genes important in the modulation of the hypothalamic–pituitary–adrenal axis and immune functions in Mexican Americans with major depression is reported and associations of several SNPs and antidepressantresponse are found. Expand
Cerebrospinal Cytokine Levels in Patients with Acute Depression
TLDR
A positive correlation was found between serum IL-1β and the severity of depression and this results indicate a unique profile for CSF proinflammatory cytokines in acute depression. Expand
Inflammation, Glutamate, and Glia in Depression: A Literature Review
TLDR
An overview of how inflammation and glutamate dysfunction contribute to the pathophysiology of depression is provided and microglia activated by excess inflammation, astroglial loss, and inappropriate glutamate receptor activation ultimately disrupt the delicate balance of neuroprotective versus neurotoxic effects in the brain. Expand
The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression
TLDR
A hypothesis integrating current concepts of neurotransmission and hypothalamus–pituitary–adrenal (HPA) axis dysregulation with findings on immunological alterations and alterations in brain morphology in MD is presented. Expand
...
1
2
3
4
5
...